Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
Byetta Approved for Use With Basal Insulin
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company BYETTA ( exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos ( pioglitazone ), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Turning Around Type 2
Type 2 diabetes may be the most common form, affecting millions of Americans. That doesn't mean it has to be a chronic condition. A healthy lifestyle can help you turn around the disease and live free of medication.